We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
If you've used illegal drugs or misused drugs you must tell DVLA - download the correct form to let them know
A review on the extent of medication errors and recommendations to reduce medication-related harm in England.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
This article assesses practices in a rural ‘township hospital’ and compares them with international evidence-based practice
Guidance for healthcare and public health commissioners on planning treatment services for dependence on prescription and over-the-counter medicines.
Among a cohort of hypertensive patients in South India: 3-months follow-up study
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Guidance for prescribing vets on the use of the cascade.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Find drug safety updates issued by MHRA
Information about new applications, post-licensing, advertising, product information and fees.
Report of the review of the evidence for dependence on, and withdrawal from, prescribed medicines.
This series brings together all documents relating to drugs licensing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.